Day traders' after-market lounge March 6, page-6

  1. 1,782 Posts.
    lightbulb Created with Sketch. 234
    DXB is a global phase 3 bio company potentially fully funded by milestone payments through to commercialization.

    Not many of those with a MC < $120m on ASX.
 
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.